Pyrimidine nucleotide synthesis is more extensive in poorly differentiated than in well‐differentiated human gastric carcinoma

Yoshihiko Maehara, Tetsuya Kusumoto, Yoshihisa Sakaguchi, Hiroki Kusumoto, Yuichiro Kido, Hideaki Anai, Keizo Sugimachi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In tissues obtained from patients undergoing gastrectomy the activities of 12 enzymes involved in pyrimidine nucleotide synthesis: cytidine triphosphate (CTP) synthetase, deoxycytidine monophosphate (dCMP) deaminase, thymidine monophosphate (dTMP) kinase, uridine (Urd), deoxycytidine (dCyd) and thymidine (dThd) kinases, Urd, deoxyuridine (dUrd) and dThd phosphoryiases, cytidine (Cyd) and dCyd deaminases, and DNA polymerase were examined in the eight‐well‐differentiated and 12 poorly differentiated gastric cancer tissues and the ten normal tissues. These cases were clinically advanced and serosal invasions were evident. Activities of these enzymes were higher in the poorly differentiated tissues than the well differentiated type and in the normal tissues. Significant differences were noted between the poorly differentiated and well‐differentiated types, in dTMP kinase (P < 0.02), dThd kinase (P < 0.05), dThd phosphorylase (P < 0.01), and DNA polymerase (P < 0.05). The authors' findings show that the level of pyrimidine nucleotide synthesis, in both de novo and salvage pathways, is higher in the poorly differentiated gastric cancer tissues than in the well‐differentiated type and suggest that antitumor drugs have an increased susceptibility in cases of poorly differentiated gastric carcinoma.

Original languageEnglish
Pages (from-to)96-101
Number of pages6
JournalCancer
Volume63
Issue number1
DOIs
Publication statusPublished - Jan 1 1989

Fingerprint

Pyrimidine Nucleotides
Stomach
dTMP kinase
Carcinoma
deoxycytidine deaminase
Thymidine Kinase
DNA-Directed DNA Polymerase
CTP synthetase
Stomach Neoplasms
DCMP Deaminase
Uridine Kinase
Deoxycytidine Kinase
Thymidine Phosphorylase
Cytidine Deaminase
Deoxyuridine
Uridine
Enzymes
Gastrectomy
Antineoplastic Agents
Thymidine

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Pyrimidine nucleotide synthesis is more extensive in poorly differentiated than in well‐differentiated human gastric carcinoma. / Maehara, Yoshihiko; Kusumoto, Tetsuya; Sakaguchi, Yoshihisa; Kusumoto, Hiroki; Kido, Yuichiro; Anai, Hideaki; Sugimachi, Keizo.

In: Cancer, Vol. 63, No. 1, 01.01.1989, p. 96-101.

Research output: Contribution to journalArticle

Maehara, Yoshihiko ; Kusumoto, Tetsuya ; Sakaguchi, Yoshihisa ; Kusumoto, Hiroki ; Kido, Yuichiro ; Anai, Hideaki ; Sugimachi, Keizo. / Pyrimidine nucleotide synthesis is more extensive in poorly differentiated than in well‐differentiated human gastric carcinoma. In: Cancer. 1989 ; Vol. 63, No. 1. pp. 96-101.
@article{5396722645f141dd8514f19ec022a1c2,
title = "Pyrimidine nucleotide synthesis is more extensive in poorly differentiated than in well‐differentiated human gastric carcinoma",
abstract = "In tissues obtained from patients undergoing gastrectomy the activities of 12 enzymes involved in pyrimidine nucleotide synthesis: cytidine triphosphate (CTP) synthetase, deoxycytidine monophosphate (dCMP) deaminase, thymidine monophosphate (dTMP) kinase, uridine (Urd), deoxycytidine (dCyd) and thymidine (dThd) kinases, Urd, deoxyuridine (dUrd) and dThd phosphoryiases, cytidine (Cyd) and dCyd deaminases, and DNA polymerase were examined in the eight‐well‐differentiated and 12 poorly differentiated gastric cancer tissues and the ten normal tissues. These cases were clinically advanced and serosal invasions were evident. Activities of these enzymes were higher in the poorly differentiated tissues than the well differentiated type and in the normal tissues. Significant differences were noted between the poorly differentiated and well‐differentiated types, in dTMP kinase (P < 0.02), dThd kinase (P < 0.05), dThd phosphorylase (P < 0.01), and DNA polymerase (P < 0.05). The authors' findings show that the level of pyrimidine nucleotide synthesis, in both de novo and salvage pathways, is higher in the poorly differentiated gastric cancer tissues than in the well‐differentiated type and suggest that antitumor drugs have an increased susceptibility in cases of poorly differentiated gastric carcinoma.",
author = "Yoshihiko Maehara and Tetsuya Kusumoto and Yoshihisa Sakaguchi and Hiroki Kusumoto and Yuichiro Kido and Hideaki Anai and Keizo Sugimachi",
year = "1989",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19890101)63:1<96::AID-CNCR2820630116>3.0.CO;2-V",
language = "English",
volume = "63",
pages = "96--101",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Pyrimidine nucleotide synthesis is more extensive in poorly differentiated than in well‐differentiated human gastric carcinoma

AU - Maehara, Yoshihiko

AU - Kusumoto, Tetsuya

AU - Sakaguchi, Yoshihisa

AU - Kusumoto, Hiroki

AU - Kido, Yuichiro

AU - Anai, Hideaki

AU - Sugimachi, Keizo

PY - 1989/1/1

Y1 - 1989/1/1

N2 - In tissues obtained from patients undergoing gastrectomy the activities of 12 enzymes involved in pyrimidine nucleotide synthesis: cytidine triphosphate (CTP) synthetase, deoxycytidine monophosphate (dCMP) deaminase, thymidine monophosphate (dTMP) kinase, uridine (Urd), deoxycytidine (dCyd) and thymidine (dThd) kinases, Urd, deoxyuridine (dUrd) and dThd phosphoryiases, cytidine (Cyd) and dCyd deaminases, and DNA polymerase were examined in the eight‐well‐differentiated and 12 poorly differentiated gastric cancer tissues and the ten normal tissues. These cases were clinically advanced and serosal invasions were evident. Activities of these enzymes were higher in the poorly differentiated tissues than the well differentiated type and in the normal tissues. Significant differences were noted between the poorly differentiated and well‐differentiated types, in dTMP kinase (P < 0.02), dThd kinase (P < 0.05), dThd phosphorylase (P < 0.01), and DNA polymerase (P < 0.05). The authors' findings show that the level of pyrimidine nucleotide synthesis, in both de novo and salvage pathways, is higher in the poorly differentiated gastric cancer tissues than in the well‐differentiated type and suggest that antitumor drugs have an increased susceptibility in cases of poorly differentiated gastric carcinoma.

AB - In tissues obtained from patients undergoing gastrectomy the activities of 12 enzymes involved in pyrimidine nucleotide synthesis: cytidine triphosphate (CTP) synthetase, deoxycytidine monophosphate (dCMP) deaminase, thymidine monophosphate (dTMP) kinase, uridine (Urd), deoxycytidine (dCyd) and thymidine (dThd) kinases, Urd, deoxyuridine (dUrd) and dThd phosphoryiases, cytidine (Cyd) and dCyd deaminases, and DNA polymerase were examined in the eight‐well‐differentiated and 12 poorly differentiated gastric cancer tissues and the ten normal tissues. These cases were clinically advanced and serosal invasions were evident. Activities of these enzymes were higher in the poorly differentiated tissues than the well differentiated type and in the normal tissues. Significant differences were noted between the poorly differentiated and well‐differentiated types, in dTMP kinase (P < 0.02), dThd kinase (P < 0.05), dThd phosphorylase (P < 0.01), and DNA polymerase (P < 0.05). The authors' findings show that the level of pyrimidine nucleotide synthesis, in both de novo and salvage pathways, is higher in the poorly differentiated gastric cancer tissues than in the well‐differentiated type and suggest that antitumor drugs have an increased susceptibility in cases of poorly differentiated gastric carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0024548665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024548665&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19890101)63:1<96::AID-CNCR2820630116>3.0.CO;2-V

DO - 10.1002/1097-0142(19890101)63:1<96::AID-CNCR2820630116>3.0.CO;2-V

M3 - Article

C2 - 2910429

AN - SCOPUS:0024548665

VL - 63

SP - 96

EP - 101

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -